Reported information available on TGF-β2 in CLD and HCC is less comprehensive so far; however, it implies that TGF-β2 also acts in a profibrogenic and tumorigenic manner in different organs, including the liver. This evidence concerns the gene TGFB2 and congenital secretory chloride diarrhea 1.